Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Cash from Investing Activities (2022 - 2025)

CervoMed (CRVO) has disclosed Cash from Investing Activities for 6 consecutive years, with $5.4 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 42.26% to $5.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.1 million through Dec 2025, up 163.14% year-over-year, with the annual reading at $18.1 million for FY2025, 163.14% up from the prior year.
  • Cash from Investing Activities hit $5.4 million in Q4 2025 for CervoMed, down from $7.6 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $9.5 million in Q1 2023 to a low of -$40.6 million in Q2 2024.
  • Historically, Cash from Investing Activities has averaged -$1.8 million across 4 years, with a median of $3.4 million in 2022.
  • Biggest five-year swings in Cash from Investing Activities: tumbled 9544.28% in 2023 and later skyrocketed 191.34% in 2025.
  • Year by year, Cash from Investing Activities stood at $7.0 million in 2022, then tumbled by 235.71% to -$9.5 million in 2023, then skyrocketed by 197.97% to $9.3 million in 2024, then tumbled by 42.26% to $5.4 million in 2025.
  • Business Quant data shows Cash from Investing Activities for CRVO at $5.4 million in Q4 2025, $7.6 million in Q3 2025, and -$254993.0 in Q2 2025.